» Articles » PMID: 36009990

Management of Pediatric Urinary Tract Infections: A Delphi Study

Abstract

Urinary tract infection (UTI) is one of the most common infectious diseases in the pediatric population and represents a major cause of antibiotic consumption and hospitalization in children. Considering the ongoing controversies on the management of pediatric UTI and the challenges due to increasing antimicrobial resistance, the aim of the present study was to evaluate the level of agreement on UTI management in pediatric age in Emilia-Romagna Region, Italy, and to assess on the basis of recent studies whether there is the need to change current recommendations used by primary care pediatricians, hospital pediatricians, and pediatric surgeons in everyday clinical practice to possibly improve outcomes. This consensus provides clear and shared indications on UTI management in pediatric age, based on the most updated literature. This work represents, in our opinion, the most complete and up-to-date collection of statements on procedures to follow for pediatric UTI, in order to guide physicians in the management of the patient, standardize approaches, and avoid abuse and misuse of antibiotics. Undoubtedly, more randomized and controlled trials are needed in the pediatric population to better define the best therapeutic management in cases with antimicrobial resistance and real usefulness of long-term antibiotic prophylaxis.

Citing Articles

Bacterial Isolates and Their Antimicrobial Susceptibility Patterns Among Pediatric Patients with Urinary Tract Infections: A Retrospective Cross-Sectional Study at Tertiary Level in Afghanistan.

Esmat E, Saadaat R, Saedi N, Hakimi A, Baryali A, Rasooli A Infect Drug Resist. 2025; 18():51-60.

PMID: 39811399 PMC: 11730758. DOI: 10.2147/IDR.S499017.


Piperacillin-Tazobactam versus Cefotaxime as Empiric Treatment for Febrile Urinary Tract Infection in Hospitalized Children.

Han K, Oh M, Ahn J, Lee J, Kim Y, Yoon Y Infect Chemother. 2024; 56(2):266-275.

PMID: 38960740 PMC: 11224032. DOI: 10.3947/ic.2024.0020.


Clinical Outcomes of Voiding Cystourethrogram and Antibiotic Prophylaxis.

AlMatrafi B, Al Otay A, Alhelaly A, Alhagbani M, Alquliti A Cureus. 2023; 15(10):e46814.

PMID: 37954724 PMC: 10636231. DOI: 10.7759/cureus.46814.


Old Folks, Bad Boon: Antimicrobial Resistance in the Infant Gut Microbiome.

Saturio S, Rey A, Samarra A, Collado M, Suarez M, Mantecon L Microorganisms. 2023; 11(8).

PMID: 37630467 PMC: 10458625. DOI: 10.3390/microorganisms11081907.


Infections in Children with Cancer Admitted in an Oncology Reference Hospital: A Cross-sectional Study.

Vieira Filho J, Ribeiro V, do Nascimento A, Maria Alves de Melo M Curr Microbiol. 2023; 80(9):315.

PMID: 37544971 DOI: 10.1007/s00284-023-03420-y.


References
1.
Koyle M, Barqawi A, Wild J, Passamaneck M, Furness 3rd P . Pediatric urinary tract infections: the role of fluoroquinolones. Pediatr Infect Dis J. 2003; 22(12):1133-7. DOI: 10.1097/01.inf.0000101849.11912.8e. View

2.
Nieminen O, Korppi M, Helminen M . Healthcare costs doubled when children had urinary tract infections caused by extended-spectrum β-lactamase-producing bacteria. Acta Paediatr. 2016; 106(2):327-333. DOI: 10.1111/apa.13656. View

3.
Mattoo T, Shaikh N, Nelson C . Contemporary Management of Urinary Tract Infection in Children. Pediatrics. 2021; 147(2). DOI: 10.1542/peds.2020-012138. View

4.
Wettergren B, Jodal U . Spontaneous clearance of asymptomatic bacteriuria in infants. Acta Paediatr Scand. 1990; 79(3):300-4. DOI: 10.1111/j.1651-2227.1990.tb11460.x. View

5.
Bachur R, Harper M . Predictive model for serious bacterial infections among infants younger than 3 months of age. Pediatrics. 2001; 108(2):311-6. DOI: 10.1542/peds.108.2.311. View